ESMO 2025: Data, decisions, and the future of oncology
This year’s congress showcased remarkable progress across multiple fronts, from next-generation immunotherapies and antibody-drug conjugates (ADCs) to the accelerating role of AI-driven…
This year’s congress showcased remarkable progress across multiple fronts, from next-generation immunotherapies and antibody-drug conjugates (ADCs) to the accelerating role of AI-driven…
Annex 1 regulations refer to a set of guidelines from the European Medicines Agency (EMA) for the manufacture of sterile…
In the fast-paced environment of pharmaceutical innovation, bioconjugation has proved to be a cornerstone technology. By enabling the precise modification…
The growing demand for contract packaging services is a testament to the added value CDMOs bring to pharmaceutical companies navigating…
Speaking at HUAWEI CONNECT 2025 in Shanghai, Leo Chen, Senior Vice President and President of Enterprise Sales at Huawei, reminded…
High-speed and high-precision micro-milling (micronisation) play a crucial role in various industries, including pharmaceuticals, food production and the development of…
The early stages of formulation development and analytical testing can be some of the most exciting phases of drug development,…
Author: Sebastian Wurst, Director, OpenData Strategy, Europe As global biopharmas expand into new markets, they introduce more systems to handle…
AI is revolutionizing drug discovery with its ability to analyze vast datasets. Particularly beneficial in the early drug discovery phase,…
The proliferation of Artificial Intelligence (AI) in our lives has set about a true revolution in how we collect, organize…